Our AIMS and SCOPES:

The aim of Innovations in Pharmacognosy and Pharmaceutical Chemistry is to provide a platform for researchers, scholars, and practitioners to share their innovative insights, methodologies, and discoveries in the fields of pharmacognosy and pharmaceutical chemistry. We welcome original research articles, reviews, and case reports that explore new insights, methodologies, and perspectives in these fields.

In order to achieve this aim, our journal is focused on several key scopes. These include, but are not limited to:

• Natural products and their chemical characterization
• Isolation and identification of bioactive compounds
• Drug design and development
• Pharmacokinetics and pharmacodynamics of natural products and synthetic compounds
• Drug delivery and formulation
• Analytical and bioanalytical methods for drug analysis
• Quality control and standardization of natural products and drugs
• Toxicity and safety assessment of natural products and drugs
• Ethnopharmacology and traditional medicine

We are particularly interested in research that explores new methodologies and approaches to these fields, as well as studies that focus on the development of novel drugs and therapies. We also welcome research that explores the potential of natural products as sources of new drugs and therapies.

In addition to our research articles, we also welcome review articles that provide a critical overview of the current state of knowledge in these fields. Our review articles should be written by experts in the field and should provide an in-depth analysis of the current literature on a specific topic. We also welcome case reports that explore novel

applications of pharmacognosy and pharmaceutical chemistry in clinical practice.

As an open-access journal, we are committed to providing free and unrestricted access to all of our published content. We believe that open access publishing is essential to promoting the dissemination of knowledge and advancing scientific research. We also follow all necessary regulations from organizations, including but not limited to, the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME).

To ensure the quality and rigor of our published content, we follow a rigorous peer-review process. All submitted manuscripts undergo a thorough evaluation by our editorial team to determine their suitability for publication. Manuscripts that meet our initial criteria are sent out for peer review by experts in the field. We aim to provide authors with timely and constructive feedback on their work and to help them improve the quality of their research and writing.

We also believe in providing a supportive and inclusive publishing environment for our authors. We aim to provide clear and transparent guidelines for manuscript submission and review, and we work closely with authors to ensure that their work meets the highest standards of quality and rigor. We also aim to provide timely and constructive feedback to our authors, helping them to improve their research and writing skills and contribute to the advancement of knowledge in these fields.

In summary, Innovations in Pharmacognosy and Pharmaceutical Chemistry is a peer-reviewed, open-access journal dedicated to publishing innovative research in the fields of pharmacognosy and pharmaceutical chemistry. Our mission is to provide a platform for researchers, scholars, and practitioners to share their innovative insights, methodologies, and discoveries in these fields, and our vision is to become a leading open-access journal in these areas. We follow all necessary regulations from organizations, prioritize academic integrity and ethical research practices, and promote diversity, equity, and inclusion in all aspects of our journal. We welcome original research articles, reviews, and case reports that explore new insights, methodologies, and perspectives in these fields, and we are committed to providing a supportive and inclusive publishing environment for our authors.

Keywords/ Subtopics:

 

1. Pharmacognosy
2. Pharmaceutical chemistry
3. Natural products
4. Drug discovery
5. Herbal medicine
6. Traditional medicine
7. Ethnopharmacology
8. Phytochemistry
9. Medicinal plants
10. Plant extracts
11. Drug development
12. Bioactive compounds
13. Pharmacology
14. Pharmacokinetics
15. Pharmacodynamics
16. Toxicology
17. Drug delivery
18. Nanoparticles
19. Formulation
20. Quality control
21. Analytical chemistry
22. Chromatography
23. Spectroscopy
24. Mass spectrometry
25. HPLC
26. GC-MS
27. NMR
28. Structure-activity relationship
29. Bioassay
30. Cell culture
31. In vitro
32. In vivo
33. Clinical trials
34. Drug metabolism

• Enzyme inhibition

36. Receptor binding

• Natural product synthesis
• Anti-inflammatory
• Anti-cancer

40. Anti-microbial
41. Anti-viral
42. Immunomodulatory
43. Neuroprotective
44. Anti-diabetic
45. Anti-oxidant
46. Anti-hypertensive
47. Cardiovascular diseases
48. Respiratory diseases
49. Infectious diseases
50. Neurodegenerative diseases
51. Metabolic disorders
52. Obesity

• Nutraceuticals

54. Dietary supplements
55. Prebiotics

• Probiotics

57. Herbal teas
58. Aromatherapy
59. Essential oils
60. Traditional Chinese medicine
61. Ayurveda
62. Kampo
63. Ethnobotany
64. Ethnomedicine

• Indigenous knowledge

66. Sustainability

• Green chemistry
• Organic synthesis
• Synthetic biology

70. Drug repurposing
71. Biopharmaceuticals
72. Immunotherapeutics

• Gene therapy

74. Biomarkers
75. Drug design

• Molecular modeling

77. Computer-aided drug design
78. Docking
79. QSAR
80. Pharmacogenomics
81. Personalized medicine
82. Precision medicine

• Drug interactions

84. Adverse effects
85. Drug safety

• Pharmacovigilance

87. Drug resistance
88. Antibiotic resistance
89. Microbial diversity
90. Microbial biotechnology
91. Fermentation
92. Biotransformation

• Bioreactor

94. Biosynthesis
95. Biocatalysis

• Enzyme engineering

97. Metabolic engineering
98. Genome editing
99. CRISPR
100. Gene editing
101. Stem cells
102. Tissue engineering
103. Regenerative medicine
104. Cell-based therapies
105. Immunotherapy
106. Vaccines
107. Pharmaceutical nanotechnology
108. Liposomes
109. Polymeric nanoparticles
110. Dendrimers
111. Carbon nanotubes
112. Gold nanoparticles
113. Silver nanoparticles
114. Quantum dots
115. Targeted drug delivery
116. Cell-penetrating peptides
117. Peptide drug conjugates
118. Antibody drug conjugates
119. Lipid-based drug delivery
120. Pulmonary drug delivery
121. Ocular drug delivery
122. Transdermal drug delivery
123. Buccal drug delivery
124. Nasal drug delivery
125. Oral drug delivery
126. Implantable drug delivery
127. Medical devices
128. Wearable devices
129. Biosensors
130. User
131. please continue further
132. ChatGPT
133. Artificial intelligence
134. Machine learning
135. Deep learning
136. Natural language processing
137. Big data analytics
138. Data mining
139. Data visualization
140. Cloud computing
141. Internet of things
142. Blockchain technology
143. Digital health
144. Telemedicine
145. E-health
146. Mobile health
147. Health informatics
148. Electronic health records
149. Health economics
150. Health policy
151. Health disparities
152. Global health
153. Community pharmacy
154. Clinical pharmacy
155. Hospital pharmacy
156. Industrial pharmacy
157. Regulatory affairs
158. Drug approval process
159. Intellectual property
160. Patent law
161. Ethics in pharmacognosy and pharmaceutical chemistry
162. Scientific communication
163. Manuscript preparation
164. Peer-review process
165. Open access publishing
166. Copyright
167. Authorship criteria
168. Conflict of interest
169. Scientific misconduct
170. Research ethics
171. Animal experimentation
172. Informed consent
173. Human subjects research
174. Clinical research
175. Good laboratory practices
176. Good clinical practices
177. Good manufacturing practices
178. Health and safety regulations
179. Environmental regulations
180. Occupational health and safety
181. Waste management
182. Quality management
183. ISO standards
184. Good documentation practices
185. Risk management
186. Health risk assessment
187. Statistical analysis
188. Data interpretation
189. Scientific writing
190. Grant proposal writing
191. Scientific conference presentation
192. Teaching pharmacognosy and pharmaceutical chemistry
193. Continuing education
194. Career development
195. Industry-academia collaboration
196. Entrepreneurship in pharmacognosy and pharmaceutical chemistry
197. Innovation in drug development
198. Patent landscape analysis
199. Market analysis
200. Competitive intelligence
201. Business development
202. Scientific outreach.